Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4


Bachelot T., Royce M., Villanueva C., Melo Cruz F., Hegg R., Falkson C., ...Daha Fazla

42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 identifier

  • Cilt numarası: 28
  • Basıldığı Şehir: Madrid
  • Basıldığı Ülke: İspanya